Cardiology

HR+

Questions discussed in this category

Would you give anthracycline chemotherapy to a patient with HR+, HER2 negative inflammatory breast cancer who has history of cardiomyopathy with LVH and moderately reduced EF but most recent echo shows improvement to normal or near normal ejection fraction?

If no anthracycline, what alternative regimen would you consider?

5 Answers available

Papers discussed in this category

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018-12-01

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.

Related Topics in Cardiology